Insider Transactions in Q2 2024 at Igm Biosciences, Inc. (IGMS)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2024
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,734
+18.6%
|
-
|
|
Jun 28
2024
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,734
+0.06%
|
-
|
|
Jun 28
2024
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
1,734
+1.96%
|
-
|
|
Jun 28
2024
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
3,078
+19.0%
|
-
|
|
Jun 28
2024
|
Elizabeth H.Z. Thompson |
BUY
Grant, award, or other acquisition
|
Direct |
1,452
+33.33%
|
-
|
|
Jun 28
2024
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
2,687
+5.49%
|
-
|
|
Jun 28
2024
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
3,988
+0.31%
|
-
|
|
Jun 14
2024
|
Steven Weber PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
495
-1.87%
|
$3,465
$7.58 P/Share
|
|
Jun 14
2024
|
Mary Beth Harler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,570
-1.81%
|
$10,990
$7.58 P/Share
|
|
Jun 14
2024
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,106
-0.56%
|
$7,742
$7.58 P/Share
|
|
Jun 14
2024
|
Fred Schwarzer CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
4,164
-1.61%
|
$29,148
$7.58 P/Share
|
|
Jun 14
2024
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,570
-1.74%
|
$10,990
$7.58 P/Share
|
|
Jun 14
2024
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,570
-1.61%
|
$10,990
$7.58 P/Share
|
|
Jun 14
2024
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
977
-1.6%
|
$6,839
$7.58 P/Share
|
|
May 15
2024
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+1.49%
|
$15,000
$5.02 P/Share
|
|
May 15
2024
|
Fred Schwarzer CEO AND PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+1.15%
|
$15,000
$5.02 P/Share
|
|
May 15
2024
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+2.99%
|
$15,000
$5.02 P/Share
|